James Cleveland
Family · Cumming, GANPI 1942895321
Payments from drug & device makers
Across 182 payments — averaging $19.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Inspire Medical Systems, Inc.$341
- Novo Nordisk$314
- Lilly USA, LLC$281
- AstraZeneca$267
- GSK$226
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,485100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 67 | $1,037 |
| Inspire Medical Systems, Inc. | 13 | $341 |
| Novo Nordisk | 18 | $314 |
| Lilly USA, LLC | 11 | $281 |
| AstraZeneca | 14 | $267 |
| GSK | 7 | $226 |
| Pfizer | 9 | $182 |
| Amgen | 7 | $119 |
| Astellas Pharma US Inc | 5 | $103 |
| Exact Sciences | 4 | $76 |
| Idorsia Pharmaceuticals US Inc | 4 | $74 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Esperion Therapeutics, Inc. | 3 | $65 |
| Dexcom, Inc. | 3 | $63 |
| Shield Therapeutics Inc | 3 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $42 |
| Abbott | 2 | $39 |
| Boehringer Ingelheim | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,494 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 17 | $18,250 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $9,706 |
| EliquisApixaban | 12 | $9,084 |
| GlyxambiEmpagliflozin/Linagliptin | 15 | $8,100 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $1,496 |
| Rosuvastatin Calcium | 71 | $1,241 |
| Atorvastatin Calcium | 65 | $509 |
| Bupropion XlBupropion Hcl | 19 | $486 |
| Losartan Potassium | 44 | $481 |
| Omeprazole | 49 | $416 |
| Tamsulosin Hcl | 24 | $354 |
| Lisinopril | 90 | $324 |
| Amitriptyline Hcl | 11 | $319 |
| Gabapentin | 32 | $311 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $301 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $281 | $18,25017 claims |
| AstraZenecaBreztri Aerosphere | $267 | $9,70615 claims |
| PfizerEliquis | $182 | $9,08412 claims |
| Boehringer IngelheimGlyxambi | $28 | $8,10015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,258 family providers in Georgia.
Other family in Cumming
- Julia BranchCumming$102K
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.